News Ocriplasmin: A Welcome Option for Vitreomacular Disease by Medscape • 2013/05/15 • 0 Comments Now approved in both the United States and Europe, the proteolytic enzyme ocriplasmin brings a less invasive treatment option for vitreomacular adhesion to the table. Medscape Ophthalmology Full Story →